for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Vanda's experimental COVID-19 drug shows promise in interim trial data

Aug 18 (Reuters) - COVID-19 patients with pneumonia improved faster when administered with its experimental therapy than those on placebo, Vanda Pharmaceuticals Inc said on Tuesday, citing an interim analysis of data from a late-stage study.

Vanda said the data was from 60 patients enrolled in the trial, which aims to enroll 300 patients eventually. (Reporting by Manas Mishra in Bengaluru; Editing by Anil D’Silva)

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up